Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 53INDUSTRY 12NIH 3OTHER_GOV 2UNKNOWN 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Lung Neoplasms 6Breast Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Neoplasms 3Pancreatic Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma 3Urinary Bladder Neoplasms 2Nasopharyngeal Carcinoma 2Hodgkin Disease 2Gallbladder Neoplasms 2Cholangiocarcinoma 2Triple Negative Breast Neoplasms 1Testicular Neoplasms 1Small Cell Lung Carcinoma 1Renal Insufficiency 1Neoplastic Cells, Circulating 1Locally Advanced Cervical Cancer 1Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement 1Carcinoma, Transitional Cell 1

Interventions

Cisplatin 5Fluorouracil 4Capecitabine 4tislelizumab 2Radiation 2Gemcitabine 2toripalimab 1temoporfin 1nimotuzumab 1fludarabine 1Taxes 1Radiotherapy, Intensity-Modulated 1Maintenance Chemotherapy 1Drug Therapy 1Cyclophosphamide 1Cell Count 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Nasopharyngeal Carcinoma × Gemcitabine × Clear all
NCT06331845 2024-03-26

Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma

Fujian Cancer Hospital

Phase 2 Not yet recruiting
39 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT00697905 2014-11-21

Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma

Ministry of Health, Malaysia

Phase 2 Completed
18 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡